Vimarsana
Biggest News Aggregation in the World

Multi Omic Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multi Omic Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multi Omic Data Today - Breaking & Trending Today

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates - Vimarsana News

Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Published: December 18, 2023

Golden, Colorado & Nashville, Tennessee, Dec. 18, 2023 -- Theralink Technologies , a precision oncology company with an exclusively licensed commercial RPPA technology platform, is excited to...

Source: marketscreener.com
Related Topics:
United StatesSan FranciscoTrevor MccartneyEmanuelf PetricoinGlobenewswire IncUniversity ProfessorUniversity Of CaliforniaGeorge Mason UniversityTheralink Technologies IncSecurities ExchangeMason Science School Of Systems BiologyExchange CommissionMason UniversityCell Reports MedicineResponse Predictive SignatureTriple Negative Breast CancerApplied ProteomicsMolecular MedicineBreast CancerDistinguished University ProfessorScience SchoolReverse Phase Protein ArraySecurities ActSecurities Exchange ActMerger Agreement
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board -November 03, 2023 at 09:16 am EDT - Vimarsana News

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board -November 03, 2023 at 09:16 am EDT

Published: November 3, 2023

Golden, Colorado, Nov. 03, 2023 -- Theralink Technologies, Inc. , a precision oncology company with its exclusive commercial RPPA technology that can help predict which FDA-approved drug is...

Source: marketscreener.com
Related Topics:
United StatesTrevor MccartneyExchange CommissionInova Schar Cancer InstituteGastrointestinal Cancer ProgramSecurities ExchangeHoldings IncTheralink Technologies IncGlobenewswire IncSchar Cancer InstituteMolecular Tumor BoardInova Schar Molecular TumorSchar CancerChief Executive OfficerInova Molecular Tumor BoardReverse Phase Protein ArraySecurities ActSecurities Exchange ActMerger AgreementQuarterly ReportsCurrent ReportsAnnual ReportsMulti Omic DataMolecular Tumor Board RevealsInhibitor Resistance
Transitioning to Precision Medicine Individualizes Patient Care - Vimarsana News

Transitioning to Precision Medicine Individualizes Patient Care

Published: May 16, 2023

Precision medicine is rooted in the reality that the way patients respond to treatment is heavily affected by their individual genetic variability, their complex biology, and external factors.

Source: pharmacytimes.com
Related Topics:
Ximena BonillaChristian OlsenAnja IrmischWhite House Office Of ScienceDrug AdministrationOrder On Advancing National BiotechnologyNational CenterBiomarker Qualification Program Educational Module SeriesHuman ServicesNational Institute Of HealthUs Department Of HealthTherapy DevelopmentHow Biomarkers Can Improve The Drug DevelopmentTumor ProfilerHarvard Business ReviewPredictive AnalysisWhite HousePresident BidenAdvancing National BiotechnologyMulti Omic DataPersonal Multi OmeAssociate Vice PresidentIndustry PrincipalAccessed AprilPatient Focused Therapy